NasdaqCM:BLFSLife Sciences
Why BioLife Solutions (BLFS) Is Up 7.8% After Swinging To Q2 Profitability And What's Next
In the second quarter of 2026, BioLife Solutions, Inc. reported sales of US$28.47 million, up from US$23.44 million a year earlier, and moved from a net loss of US$15.84 million to net income of US$45.1 million, with basic earnings per share from continuing operations rising from a loss of US$0.32 to earnings of US$0.92.
For the first half of 2026, the company’s sales increased to US$55.97 million from US$45.49 million, while net income shifted from a loss of US$16.29 million to a profit of...